About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDNA

Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study

A Pilot Study on Effectiveness and Safety of Moxibustion for Benign Prostate Hyperplasia With Lower Urinary Tract Syndrome

NCT02051036•JUNGNAM KWON

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

BPHBenign Prostatic HyperplasiaBenign Prostatic Hypertrophy+1 more

Interventions

Moxibustion

Locations

1

South Korea

Locations (1)

National Clinical Research Center, Korean Medicine Hospital, Pusan National University

Yangsa, Kyungsangnamdo, South Korea

Key Dates

Start Date

February 1, 2014

Primary Completion Date

December 1, 2015

Completion Date

December 1, 2015

Last Updated

April 9, 2019

Related Studies

Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction

NCT05574244

Benign Prostatic Hyperplasia

Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)

NCT03297281

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction

Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia

NCT07016620

Benign Prostatic Hyperplasia (BPH)

Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

NCT07377929

Benign Prostatic Hypertrophy (BPH)Lower Urinary Track Symptoms

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

NCT06312722

Benign Prostatic Hyperplasia

Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging

NCT06817733

Benign Prostatic Hyperplasia (BPH)

View all related studies

Sponsors

Lead Sponsor

JUNGNAM KWON

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2019Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions